STOCK TITAN

Trust of Arteris (AIP) director Wayne Cantwell sells 38,500 shares

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Arteris, Inc. director Wayne C. Cantwell reported an open-market sale of Common Stock through The Cantwell Living Trust on May 26, 2026. The trust sold 38,500 shares at a weighted average price of $37.2251 per share, in multiple trades between $36.79 and $37.55.

After the sale, The Cantwell Living Trust held 189,698 Arteris shares. Separate holding entries show Cantwell with 34,732 shares held directly and 38,761 shares held indirectly through the Decathlon Capital Management 401K Plan FBO Wayne Cantwell.

Positive

  • None.

Negative

  • None.

Insights

Director-linked trust sold 38,500 Arteris shares but retains a sizable stake.

The filing shows an open-market sale of 38,500 Arteris common shares on May 26, 2026 by The Cantwell Living Trust, associated with director Wayne C. Cantwell as trustee. The weighted average sale price was about $37.23, across a range of $36.79–$37.55.

Following the sale, the trust still holds 189,698 shares, and additional positions appear in a 401(k) plan (38,761 shares) and direct ownership (34,732 shares). This indicates a partial reduction rather than an exit, with no derivative exercises or tax-withholding transactions disclosed in this filing.

Insider Cantwell Wayne C
Role null
Sold 38,500 shs ($1.43M)
Type Security Shares Price Value
Sale Common Stock 38,500 $37.2251 $1.43M
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 189,698 shares (Indirect, The Cantwell Living Trust); Common Stock — 34,732 shares (Direct, null)
Footnotes (1)
  1. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.79 to $37.55 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares are held by The Cantwell Living Trust, for which the Reporting Person serves as trustee.
Shares sold 38,500 shares Open-market sale on May 26, 2026
Weighted average sale price $37.2251 per share Common Stock sale by The Cantwell Living Trust
Post-sale trust holdings 189,698 shares Shares held by The Cantwell Living Trust after sale
Indirect 401(k) holdings 38,761 shares Held by Decathlon Capital Management 401K Plan FBO Wayne Cantwell
Direct holdings 34,732 shares Direct ownership by Wayne C. Cantwell after reported transactions
Sale price range $36.79–$37.55 per share Range of prices for individual trades in the sale
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect ownership financial
""ownership_type": "indirect""
trustee financial
"The shares are held by The Cantwell Living Trust, for which the Reporting Person serves as trustee."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cantwell Wayne C

(Last)(First)(Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300

(Street)
CAMPBELL CALIFORNIA 95008

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/26/2026S38,500D$37.2251(1)189,698IThe Cantwell Living Trust(2)
Common Stock34,732D
Common Stock38,761IBy: Decathlon Capital Management 401K Plan FBO Wayne Cantwell
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.79 to $37.55 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. The shares are held by The Cantwell Living Trust, for which the Reporting Person serves as trustee.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for Cantwell Wayne C05/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Arteris (AIP) report for Wayne C. Cantwell?

Arteris reported that a trust associated with director Wayne C. Cantwell sold 38,500 shares of Common Stock. The Cantwell Living Trust executed an open-market sale and still holds a significant remaining stake in Arteris after this transaction.

How many Arteris (AIP) shares did The Cantwell Living Trust sell and at what price?

The Cantwell Living Trust sold 38,500 Arteris shares at a weighted average price of $37.2251. The sale occurred through multiple trades, with individual prices ranging from $36.79 to $37.55 per share, according to the Form 4 disclosure.

How many Arteris (AIP) shares does The Cantwell Living Trust hold after the sale?

After the disclosed sale, The Cantwell Living Trust holds 189,698 Arteris common shares. This position reflects the trust’s remaining indirect ownership associated with director Wayne C. Cantwell, who serves as trustee for the trust.

What are Wayne C. Cantwell’s other reported Arteris (AIP) holdings?

In addition to the trust position, the filing shows 38,761 Arteris shares held indirectly through the Decathlon Capital Management 401K Plan FBO Wayne Cantwell and 34,732 shares held directly. These entries represent reported holdings, not new transactions.

Was the Arteris (AIP) insider sale made in the open market?

Yes. The Form 4 describes the 38,500-share transaction as an open-market sale of Arteris Common Stock. The footnote notes a weighted average sale price based on multiple trades within a specified price range on the transaction date.

Who is the seller of the Arteris (AIP) shares in this Form 4 filing?

The seller is The Cantwell Living Trust, which holds Arteris shares for the benefit of director Wayne C. Cantwell. The footnote explains that Cantwell serves as trustee of the trust, which conducted the reported open-market sale.